In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases.
作者信息
Kitzis M D, Liassine N, Ferré B, Gutmann L, Acar J F, Goldstein F
机构信息
Laboratoire de Microbiologie Médicale, Hôpital Saint-Joseph, Paris, France.
出版信息
Antimicrob Agents Chemother. 1990 Sep;34(9):1783-6. doi: 10.1128/AAC.34.9.1783.
Abstract
The activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases were studied. All compounds were affected by these enzymes, especially by the SHV derivatives. Except for ceftibuten, the compounds with the greatest intrinsic activity were more affected by the presence of these enzymes than were older compounds with moderate intrinsic activity.
摘要
相似文献
1
In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases.
Antimicrob Agents Chemother. 1990 Sep;34(9):1783-6. doi: 10.1128/AAC.34.9.1783.
2
Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.不同β-内酰胺类药物对产超广谱β-内酰胺酶肺炎克雷伯菌菌株在大鼠腹腔脓肿模型中的疗效
Antimicrob Agents Chemother. 1991 Jun;35(6):1243-4. doi: 10.1128/AAC.35.6.1243.
3
In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases.NXL104与β-内酰胺类药物联合对产KPC碳青霉烯酶的肺炎克雷伯菌分离株的体外活性。
Antimicrob Agents Chemother. 2009 Aug;53(8):3599-601. doi: 10.1128/AAC.00641-09. Epub 2009 Jun 15.
4
Characterization of the extended-spectrum beta-lactamases and determination of the antibiotic susceptibilities of Klebsiella pneumoniae isolates in Hungary.匈牙利肺炎克雷伯菌分离株的超广谱β-内酰胺酶特性及抗生素敏感性测定
J Antimicrob Chemother. 1998 Sep;42(3):401-3. doi: 10.1093/jac/42.3.401.
5
[Comparative antibacterial activity of ceftibuten (SH 39 720) against 150 K. pneumoniae strains producing different beta-lactamases].
Pathol Biol (Paris). 1990 May;38(5):347-51.
6
7
Interactions of ceftibuten with extended-spectrum beta-lactamases: a bacteriological and enzymatic analysis.头孢布烯与超广谱β-内酰胺酶的相互作用：细菌学和酶学分析
Drugs Exp Clin Res. 1994;20(2):49-54.
8
Russian Klebsiella pneumoniae isolates that express extended-spectrum beta-lactamases.表达超广谱β-内酰胺酶的俄罗斯肺炎克雷伯菌分离株。
Clin Microbiol Infect. 2000 Feb;6(2):103-8. doi: 10.1046/j.1469-0691.2000.00016-2.x.
9
The frequency of extended-spectrum beta-lactamases in isolates of Klebsiella pneumoniae.
J Antimicrob Chemother. 1992 Mar;29(3):345-6. doi: 10.1093/jac/29.3.345.
10
Klebsiella pneumoniae strains carrying the chromosomal SHV-11 beta-lactamase gene produce the plasmid-mediated SHV-12 extended-spectrum beta-lactamase more frequently than those carrying the chromosomal SHV-1 beta-lactamase gene.携带染色体SHV-11β-内酰胺酶基因的肺炎克雷伯菌菌株比携带染色体SHV-1β-内酰胺酶基因的菌株更频繁地产生质粒介导的SHV-12超广谱β-内酰胺酶。
J Antimicrob Chemother. 2006 Jun;57(6):1259-61. doi: 10.1093/jac/dkl115. Epub 2006 Apr 4.
引用本文的文献
1
Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects.亚胺培南和美罗培南：体外活性、药代动力学、临床试验及不良反应的比较
Can J Infect Dis. 1998 Jul;9(4):215-28. doi: 10.1155/1998/831425.
2
Activities of oral antibiotics on Providencia strains isolated from institutionalized elderly patients with urinary tract infections.口服抗生素对从患有尿路感染的机构养老患者中分离出的普罗威登斯菌菌株的活性。
Antimicrob Agents Chemother. 1995 Dec;39(12):2819-21. doi: 10.1128/AAC.39.12.2819.
3
Cefetamet pivoxil clinical pharmacokinetics.头孢他美酯的临床药代动力学。
Clin Pharmacokinet. 1993 Sep;25(3):172-88. doi: 10.2165/00003088-199325030-00002.
4
Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.头孢布烯的药代动力学和药效学。重点关注儿科应用。
Clin Pharmacokinet. 1994 Mar;26(3):169-89. doi: 10.2165/00003088-199426030-00002.
5
Comparative microbiological activity and pharmacokinetics of cefprozil.
Eur J Clin Microbiol Infect Dis. 1994 Oct;13(10):839-45. doi: 10.1007/BF02111350.
6
Origin and impact of plasmid-mediated extended-spectrum beta-lactamases.质粒介导的超广谱β-内酰胺酶的起源与影响
Eur J Clin Microbiol Infect Dis. 1994;13 Suppl 1:S17-29. doi: 10.1007/BF02390681.
7
Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.氯碳头孢。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1993 May;45(5):716-36. doi: 10.2165/00003495-199345050-00008.
8
Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢他美酯。其抗菌活性、药代动力学特性及治疗用途综述。
Drugs. 1993 Apr;45(4):589-621. doi: 10.2165/00003495-199345040-00009.
9
Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.美罗培南：抗菌活性、药代动力学特性及临床疗效综述
Drugs. 1995 Jul;50(1):73-101. doi: 10.2165/00003495-199550010-00007.
10
Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
Drugs. 1994 May;47(5):784-808. doi: 10.2165/00003495-199447050-00006.
本文引用的文献
1
Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.肺炎克雷伯菌和粘质沙雷氏菌临床分离株对头孢噻肟、头孢西丁、头孢孟多和头孢呋辛的可转移性耐药性。
Infection. 1983 Nov-Dec;11(6):315-7. doi: 10.1007/BF01641355.
2
Translocation of sequences encoding antibiotic resistance from the chromosome to a receptor plasmid in Salmonella ordonez.编码抗生素抗性的序列在奥尔东内斯沙门氏菌中从染色体易位至受体质粒。
Mol Gen Genet. 1981;182(3):390-408. doi: 10.1007/BF00293927.
3
Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase.肺炎克雷伯菌临床分离株对第三代头孢菌素的可转移耐药性：新型β-内酰胺酶CTX-1的鉴定
J Antimicrob Chemother. 1987 Sep;20(3):323-34. doi: 10.1093/jac/20.3.323.
4
Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins.大肠杆菌中携带的新型R因子β-内酰胺酶赋予对头孢菌素的抗性。
Infection. 1987 Jul-Aug;15(4):257-9. doi: 10.1007/BF01644127.
5
Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.产超广谱β-内酰胺酶导致肠杆菌科细菌对新型β-内酰胺类药物产生可转移耐药性：医院流行情况及药敏模式
Rev Infect Dis. 1988 Jul-Aug;10(4):867-78. doi: 10.1093/clinids/10.4.867.
6
Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.新型质粒介导的β-内酰胺酶CAZ-2与赋予对广谱头孢菌素耐药性的CTX-1和CAZ-1酶的比较研究。
Antimicrob Agents Chemother. 1988 Nov;32(11):1660-5. doi: 10.1128/AAC.32.11.1660.
7
Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes.由TEM型青霉素酶基因点突变引起的质粒介导的对第三代头孢菌素的耐药性。
Rev Infect Dis. 1988 Jul-Aug;10(4):879-84. doi: 10.1093/clinids/10.4.879.
8
Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam.
Rev Infect Dis. 1988 Jul-Aug;10(4):860-6. doi: 10.1093/clinids/10.4.860.
9
Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.多重耐药肺炎克雷伯菌医院感染暴发期间对第三代头孢菌素的可转移酶耐药性
Lancet. 1987 Aug 8;2(8554):302-6. doi: 10.1016/s0140-6736(87)90891-9.
10
Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors.新型质粒介导的β-内酰胺酶CTX-1的传播，该酶赋予对广谱头孢菌素的耐药性，以及其被β-内酰胺酶抑制剂的抑制作用。
Antimicrob Agents Chemother. 1988 Jan;32(1):9-14. doi: 10.1128/AAC.32.1.9.
Zotero 插件